Report for Huwyler J

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (4)

Title : Aryl- and heteroaryl-substituted aminobenzo[a]quinolizines as dipeptidyl peptidase IV inhibitors - Boehringer_2010_Bioorg.Med.Chem.Lett_20_1106
Author(s) : Boehringer M , Fischer H , Hennig M , Hunziker D , Huwyler J , Kuhn B , Loeffler BM , Luebbers T , Mattei P , Narquizian R , Sebokova E , Sprecher U , Wessel HP
Ref : Bioorganic & Medicinal Chemistry Lett , 20 :1106 , 2010
Abstract : Boehringer_2010_Bioorg.Med.Chem.Lett_20_1106
ESTHER : Boehringer_2010_Bioorg.Med.Chem.Lett_20_1106
PubMedSearch : Boehringer_2010_Bioorg.Med.Chem.Lett_20_1106
PubMedID: 20031408
Gene_locus related to this paper: human-DPP4

Title : Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 4. In vivo active potent and selective non-competitive metabotropic glutamate receptor 2\/3 antagonists - Woltering_2010_Bioorg.Med.Chem.Lett_20_6969
Author(s) : Woltering TJ , Wichmann J , Goetschi E , Knoflach F , Ballard TM , Huwyler J , Gatti S
Ref : Bioorganic & Medicinal Chemistry Lett , 20 :6969 , 2010
Abstract : Woltering_2010_Bioorg.Med.Chem.Lett_20_6969
ESTHER : Woltering_2010_Bioorg.Med.Chem.Lett_20_6969
PubMedSearch : Woltering_2010_Bioorg.Med.Chem.Lett_20_6969
PubMedID: 20971004

Title : Discovery of carmegliptin: a potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes - Mattei_2010_Bioorg.Med.Chem.Lett_20_1109
Author(s) : Mattei P , Boehringer M , Di Giorgio P , Fischer H , Hennig M , Huwyler J , Kocer B , Kuhn B , Loeffler BM , Macdonald A , Narquizian R , Rauber E , Sebokova E , Sprecher U
Ref : Bioorganic & Medicinal Chemistry Lett , 20 :1109 , 2010
Abstract : Mattei_2010_Bioorg.Med.Chem.Lett_20_1109
ESTHER : Mattei_2010_Bioorg.Med.Chem.Lett_20_1109
PubMedSearch : Mattei_2010_Bioorg.Med.Chem.Lett_20_1109
PubMedID: 20031405
Gene_locus related to this paper: human-DPP4

Title : Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine - Grottick_2000_J.Pharmacol.Exp.Ther_294_1112
Author(s) : Grottick AJ , Trube G , Corrigall WA , Huwyler J , Malherbe P , Wyler R , Higgins GA
Ref : Journal of Pharmacology & Experimental Therapeutics , 294 :1112 , 2000
Abstract : Grottick_2000_J.Pharmacol.Exp.Ther_294_1112
ESTHER : Grottick_2000_J.Pharmacol.Exp.Ther_294_1112
PubMedSearch : Grottick_2000_J.Pharmacol.Exp.Ther_294_1112
PubMedID: 10945867